Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium prophylaxis for prevention of post-ERCP pancreatitis
ISRCTN46556454Phase 3Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) comparing Magnesium arm with Placebo arm (2 arms). Primary endpoint: Incidence of post-ERCP pancreatitis. Started Jun 2009; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on ISRCTN46556454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46556454.